Short Bowel Syndrome Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Short Bowel Syndrome Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global short bowel syndrome market is expected to grow at a CAGR of around 6.3% during 2023-2030. This report on global short bowel syndrome market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global short bowel syndrome market by segmenting the market based on drug class, application and region. Also, detailed profiles of companies operating in the short bowel syndrome market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Acceptance of Short Bowel Syndrome Treatment
• Growing Prescriptions for the Gattex Therapy
• Strong Pipeline Drugs

Market Challenges

• Dangerous Side Effects Restrict Demand
• Changes in Splanchnic Perfusion

Historical & Forecast Period

Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030

Market by Drug Class

• Glucagon-like Peptide-2 (GLP-2)
• Growth Hormone
• Glutamine
• Others

Market by Application

• Hospitals
• Clinics

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa